These results clearly demonstrate that the PTMT‐T cell is capable of downregulating inflammation‐related signaling pathway NF‐κB and of suppressing cytokine storm in severe COVID‐19 patients’ PBMCs and LPS‐treated HUVECs. Here, NFKB1 is linked to COVID-19.